Follow Us TR

News Details

Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer

About Agenus Inc.
  • NASDAQ: $AGEN
  • Notified: $5.52
  • 08:30 EDT

Price Chart